Dr. Nathan Price

Dr. Nathan Price, Chief Executive Officer, Onegevity

Dr. Nathan Price has served as Co-Chief Executive Officer for Onegevity Health, LLC, from November 2020 until its merger with our Company in March 2021. Post-merger, Dr. Price will be the Chief Executive Officer of Onegevity, a division of our company. Dr. Price has also served on the Board of Directors of Health and Environmental Sciences, a non-profit, since 2018. Since 2017, Dr. Price has co-led the Hood-Price Integrated Lab for Systems Biomedicine with biotechnology pioneer Lee Hood. Prior to his current roles, Dr. Price served as co-founder and Director of Arivale Inc. from 2014 to 2019. He has also served on many advisory boards, including Roche (Personalized Healthcare Division), Providence St. Joseph Health, Sera Prognostics, Navican, Basepaws, Trelys and the Novo Nordisk Foundation Center for Biosustainability. Dr. Price holds a Ph.D. in Bioengineering from the University of California, San Diego, an M.S. in Bioengineering from the University of California, San Diego and a B.S. in Chemical Engineering from Brigham Young University.